" 1271.10 
are my hct/p's regulated solely under section 361 of the phs act and the regulations in this part, and if so what must i do? 
(a) an hct/p is regulated solely under section 361 of the phs act and the regulations in this part if it meets all of the following criteria: 
(1) the hct/p is minimally manipulated; 
(2) the hct/p is intended for homologous use only, as reflected by the labeling, advertising, or other indications of the manufacturer's objective intent; 
(3) the manufacture of the hct/p does not involve the combination of the cells or tissues with another article, except for water, crystalloids, or a sterilizing, preserving, or storage agent, provided that the addition of water, crystalloids, or the sterilizing, preserving, or storage agent does not raise new clinical safety concerns with respect to the hct/p; and 
(4) either: 
(i) the hct/p does not have a systemic effect and is not dependent upon the metabolic activity of living cells for its primary function; or 
(ii) the hct/p has a systemic effect or is dependent upon the metabolic activity of living cells for its primary function, and: 
) is for autologous use; 
) is for allogeneic use in a first-degree or second-degree blood relative; or 
) is for reproductive use. 
(b) if you are a domestic or foreign establishment that manufactures an hct/p described in paragraph (a) of this section: 
(1) you must register with fda; 
(2) you must submit to fda a list of each hct/p manufactured; and 
(3) you must comply with the other requirements contained in this part. 

